发明申请
US20130197002A1 BRIMONIDINE FOR TREATING VISUAL DISORDERS MEDIATED BY CENTRAL VISUAL PROJECTIONS FROM THE EYE 审中-公开
用于治疗眼睛中央视觉投射介导的视觉障碍的甘露辛

  • 专利标题: BRIMONIDINE FOR TREATING VISUAL DISORDERS MEDIATED BY CENTRAL VISUAL PROJECTIONS FROM THE EYE
  • 专利标题(中): 用于治疗眼睛中央视觉投射介导的视觉障碍的甘露辛
  • 申请号: US13752871
    申请日: 2013-01-29
  • 公开(公告)号: US20130197002A1
    公开(公告)日: 2013-08-01
  • 发明人: Ursula StaubliAlan C. FosterDaniel W. GilJohn E. Donello
  • 申请人: Allergan, Inc.
  • 申请人地址: US CA Irvine
  • 专利权人: ALLERGAN, INC.
  • 当前专利权人: ALLERGAN, INC.
  • 当前专利权人地址: US CA Irvine
  • 主分类号: A61K31/498
  • IPC分类号: A61K31/498
BRIMONIDINE FOR TREATING VISUAL DISORDERS MEDIATED BY CENTRAL VISUAL PROJECTIONS FROM THE EYE
摘要:
The present invention relates to a method for treating visual disorders mediated by lateral geniculate nucleus, superior colliculus and the visual cortex by administering to a patient in need of such treatment, compounds acting at the alpha 2 adrenergic receptor.
信息查询
0/0